{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05712356",
            "orgStudyIdInfo": {
                "id": "LSTA1-P02"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-503740-14",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Lisata Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors",
            "officialTitle": "A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors (BOLSTER)",
            "acronym": "BOLSTER",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-when-added-to-standard-of-care-versus-standard-of-care-alone-in-patients-with-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-26",
            "studyFirstSubmitQcDate": "2023-01-26",
            "studyFirstPostDateStruct": {
                "date": "2023-02-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Lisata Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to test a new drug plus standard treatment compared with standard treatment alone in patients with previously untreated cholangiocarcinoma or those that have progressed after first-line treatment for cholangiocarcinoma.\n\nThe main questions it aims to answer are:\n\n* is the new drug plus standard treatment safe and tolerable\n* is the new drug plus standard treatment more effective than standard treatment",
            "detailedDescription": "This is a Phase 2a, double-blind, placebo-controlled, multi-center, randomized study of LSTA1 when added to standard of care (SoC) versus SoC alone in patients with advanced solid tumors. The study will include patients with previously untreated cholangiocarcinoma or those that have progressed after first-line treatment for cholangiocarcinoma.\n\nThe study will consist of a screening period, a run-in period, a treatment period, an end-of-treatment follow-up visit, and a long-term follow up period.\n\nParticipants who provide informed consent will be screened for eligibility within 28 days prior to beginning the study treatment run-in period. Once eligibility is confirmed, participants will be randomized to one of the two treatment groups (SoC + placebo vs. SoC + LSTA1).\n\nDuring the 3-day run-in period, participants will only receive the LSTA1 or placebo components of their randomized treatment regimen. After the 3-day run-in, Cycle 1 of treatment will commence. Tumor scans will be performed every 8 weeks (56 days \u00b1 7 days) while on treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Cholangiocarcinoma",
                "Gallbladder Cancer",
                "Gallbladder Carcinoma",
                "Intrahepatic Cholangiocarcinoma",
                "Extrahepatic Cholangiocarcinoma",
                "Bile Duct Cancer",
                "Gall Bladder Cancer",
                "Gall Bladder Carcinoma"
            ],
            "keywords": [
                "immunotherapy",
                "chemo",
                "chemotherapy",
                "first line",
                "second line",
                "progression"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "LSTA1 arm for Untreated Cholangiocarcinoma",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: LSTA1",
                        "Drug: Durvalumab",
                        "Drug: Cisplatin",
                        "Drug: Gemcitabine"
                    ]
                },
                {
                    "label": "LSTA1 arm for Second-Line Cholangiocarcinoma",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: LSTA1",
                        "Drug: FOLFOX regimen"
                    ]
                },
                {
                    "label": "Placebo arm for Untreated Cholangiocarcinoma",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Durvalumab",
                        "Drug: Cisplatin",
                        "Drug: Gemcitabine",
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Placebo arm for Second-Line Cholangiocarcinoma",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: FOLFOX regimen",
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "LSTA1",
                    "description": "LSTA1 3.2 mg/kg given as a slow IV push over 1 minute when standard treatment(s) are given",
                    "armGroupLabels": [
                        "LSTA1 arm for Second-Line Cholangiocarcinoma",
                        "LSTA1 arm for Untreated Cholangiocarcinoma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Durvalumab",
                    "description": "1500 mg of durvalumab IV administered over 1 hour every 21 days for 8 cycles then every 28 days for additional cycles",
                    "armGroupLabels": [
                        "LSTA1 arm for Untreated Cholangiocarcinoma",
                        "Placebo arm for Untreated Cholangiocarcinoma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cisplatin",
                    "description": "cisplatin 25 mg/m\u00b2 IV administered over 30 minutes on day 1 and day 8 every 21 days for up to 8 cycles",
                    "armGroupLabels": [
                        "LSTA1 arm for Untreated Cholangiocarcinoma",
                        "Placebo arm for Untreated Cholangiocarcinoma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Gemcitabine",
                    "description": "gemcitabine 1000 mg/m\u00b2 IV administered over 30 minutes on day 1 and day 8 every 21 days for up to 8 cycles",
                    "armGroupLabels": [
                        "LSTA1 arm for Untreated Cholangiocarcinoma",
                        "Placebo arm for Untreated Cholangiocarcinoma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "FOLFOX regimen",
                    "description": "The following will be given every 14 days:\n\n* oxaliplatin 85 mg/m\u00b2 and l-folinic acid 200 mg/m\u00b2 or d,l-folinic acid 400 mg/m\u00b2 concurrently, as a 2-hour IV infusion\n* fluorouracil (5-FU) 400 mg/m\u00b2 will be given as an IV bolus over 5 minutes\n* fluorouracil (5-FU) 2400 mg/m\u00b2 will be administered over 46 hours (via home-infusion pump)",
                    "armGroupLabels": [
                        "LSTA1 arm for Second-Line Cholangiocarcinoma",
                        "Placebo arm for Second-Line Cholangiocarcinoma"
                    ],
                    "otherNames": [
                        "Oxaliplatin",
                        "Folinic acid",
                        "Fluorouracil"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo given as a slow IV push over 1 minute when standard treatment(s) are given",
                    "armGroupLabels": [
                        "Placebo arm for Second-Line Cholangiocarcinoma",
                        "Placebo arm for Untreated Cholangiocarcinoma"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of adverse events",
                    "description": "The National Cancer Institute Common Terminology Criteria for Adverse Events Version 5.0 (NCI CTCAE) will be used to grade the intensity of adverse events throughout the study",
                    "timeFrame": "30 days after treatment discontinuation"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1\n* Life expectancy \u2265 3 months\n* At least one measurable lesion as assessed by RECIST 1.1\n* Adequate organ and marrow function\n* Adequate contraception\n* Patients with either of the following:\n\n  * Pathologically confirmed metastatic or unresectable cholangiocarcinoma or gallbladder carcinoma (GBC), with no prior systemic chemotherapy or targeted therapy or loco-regional therapy (including but not limited to transarterial chemoembolization, transarterial embolization, transarterial chemotherapy or transarterial radioembolization). Patients with recurrent disease more than 6 months after completion of adjuvant chemotherapy following curative resection are eligible.\n  * Pathologically confirmed metastatic or unresectable cholangiocarcinoma or GBC with progression of disease after first-line chemotherapy and immunotherapy.\n\nExclusion Criteria:\n\n* Any condition or comorbidity that, in the opinion of the investigator, would interfere with evaluation of study treatment or interpretation of patient safety or study results, including but not limited to:\n\n  * Any major surgery or irradiation less than 4 weeks prior to baseline disease assessment\n  * Active infection (viral, fungal, or bacterial) requiring systemic therapy\n  * Known active hepatitis B virus, hepatitis C virus, or HIV infection\n  * Active tuberculosis as defined per local guidance\n  * History of allogeneic tissue/solid organ transplant\n  * Prior malignancy requiring active treatment within the previous 3 years except for locally curable cancers that have been apparently cured, such as basal or squamous cell skin cancer, superficial bladder cancer, or carcinoma in situ of the prostate, cervix, or breast\n  * Pregnant or breastfeeding\n  * Clinically significant or symptomatic cardiovascular/cerebrovascular disease (incl. myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) within 6 months before randomization\n* History or clinical evidence of symptomatic central nervous system (CNS) metastases\n* For first-line cholangiocarcinoma, active autoimmune disease that might deteriorate when receiving an immune-stimulatory agent. Patients with Type 1 diabetes, vitiligo, psoriasis, or hypo- or hyperthyroid diseases not requiring immunosuppressive treatment are eligible.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kathryn Shantz",
                    "role": "CONTACT",
                    "phone": "484-437-6500",
                    "email": "kshantz@lisata.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kristen K Buck, MD",
                    "affiliation": "Lisata Therapeutics, Inc.",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "Banner MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Gilbert",
                    "state": "Arizona",
                    "zip": "85234",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Madappa Kundranda, MD, PhD",
                            "role": "CONTACT",
                            "phone": "480-256-6444",
                            "email": "Madappa.kundranda@bannerhealth.com"
                        },
                        {
                            "name": "Madappa Kundranda, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.35283,
                        "lon": -111.78903
                    }
                },
                {
                    "facility": "Mayo Clinic Arizona",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85054",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials Referral Office",
                            "role": "CONTACT",
                            "phone": "855-776-0015"
                        },
                        {
                            "name": "Bassam Sonbol, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "University of Arizona Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85719",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Prisca Zimmerman",
                            "role": "CONTACT",
                            "email": "priscaz@arizona.edu"
                        },
                        {
                            "name": "Rachna Shroff, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Providence Medical Foundation",
                    "status": "WITHDRAWN",
                    "city": "Fullerton",
                    "state": "California",
                    "zip": "92835",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.87029,
                        "lon": -117.92534
                    }
                },
                {
                    "facility": "Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Taylor Atkinson",
                            "role": "CONTACT"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "813-745-6851",
                            "email": "Taylor.Atkinson@moffitt.org"
                        },
                        {
                            "name": "Richard Kim, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Alliance for Multispecialty Research",
                    "status": "TERMINATED",
                    "city": "Merriam",
                    "state": "Kansas",
                    "zip": "66204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.02362,
                        "lon": -94.69357
                    }
                },
                {
                    "facility": "University of Kansas Cancer Center",
                    "status": "RECRUITING",
                    "city": "Westwood",
                    "state": "Kansas",
                    "zip": "66205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shannon Bradbury",
                            "role": "CONTACT",
                            "email": "sbradbury@kumc.edu"
                        },
                        {
                            "name": "Anup Kasi, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.04056,
                        "lon": -94.6169
                    }
                },
                {
                    "facility": "University of Kentucky Medical Center",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40536",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Howard",
                            "role": "CONTACT",
                            "phone": "859-323-8749"
                        },
                        {
                            "name": "Susanne Arnold, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                },
                {
                    "facility": "Norton Cancer Institute, Downtown",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "MISC-NCIResearch@nortonhealthcare.org"
                        },
                        {
                            "name": "Michael Driscoll, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Norton Cancer Institute, Audubon",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40217",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "MISC-NCIResearch@nortonhealthcare.org"
                        },
                        {
                            "name": "Michael Driscoll, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Mayo Clinic Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials Referral Office",
                            "role": "CONTACT",
                            "phone": "855-776-0015"
                        },
                        {
                            "name": "Nguyen Tran, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Comprehensive Cancer Centers of Nevada",
                    "status": "WITHDRAWN",
                    "city": "Las Vegas",
                    "state": "Nevada",
                    "zip": "89169",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.17497,
                        "lon": -115.13722
                    }
                },
                {
                    "facility": "Northwell Health - Zuckerberg Cancer Center",
                    "status": "TERMINATED",
                    "city": "Lake Success",
                    "state": "New York",
                    "zip": "11042",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.77066,
                        "lon": -73.71763
                    }
                },
                {
                    "facility": "Stony Brook Cancer Center",
                    "status": "TERMINATED",
                    "city": "Stony Brook",
                    "state": "New York",
                    "zip": "11794",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.92565,
                        "lon": -73.14094
                    }
                },
                {
                    "facility": "Novant Health Cancer Institute",
                    "status": "WITHDRAWN",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "FirstHealth of the Carolinas, Inc.",
                    "status": "RECRUITING",
                    "city": "Pinehurst",
                    "state": "North Carolina",
                    "zip": "28374",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lindsey Ferry",
                            "role": "CONTACT",
                            "phone": "910-715-2200",
                            "email": "lferry@firsthealth.org"
                        },
                        {
                            "name": "Charles Kuzma, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.19543,
                        "lon": -79.46948
                    }
                },
                {
                    "facility": "Novant Health Cancer Institute",
                    "status": "WITHDRAWN",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27103",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                },
                {
                    "facility": "Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45219",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Abby Reed, RN",
                            "role": "CONTACT",
                            "phone": "513-585-0844"
                        },
                        {
                            "name": "Alexander Starodub, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Spartanburg Medical Center",
                    "status": "RECRUITING",
                    "city": "Spartanburg",
                    "state": "South Carolina",
                    "zip": "29303",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kristen Ford",
                            "role": "CONTACT",
                            "phone": "864-530-6554",
                            "email": "kford@gibbscc.org"
                        },
                        {
                            "name": "Vikas Dembla, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.94957,
                        "lon": -81.93205
                    }
                },
                {
                    "facility": "Vanderbilt University Medical Center",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "VUMC Patient Recruitment Office",
                            "role": "CONTACT",
                            "phone": "800-811-8480",
                            "email": "CTIP@VUMC.ORG"
                        },
                        {
                            "name": "Thatcher Heumann, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "University of Texas Southwestern Medical Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ellen Siglinsky",
                            "role": "CONTACT",
                            "phone": "214-645-9684",
                            "email": "ellen.siglinsky@utsouthwestern.edu"
                        },
                        {
                            "name": "David Hsieh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "The University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ian Hu, MD, PhD",
                            "role": "CONTACT",
                            "email": "GIClinicalTrials@mdanderson.org"
                        },
                        {
                            "name": "Ian Hu, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Inova Schar Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephanie Van Bebber",
                            "role": "CONTACT",
                            "phone": "571-472-4724",
                            "email": "Stephanie.VanBebber@inova.org"
                        },
                        {
                            "name": "Raymond Wadlow, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Hospital Universitario de Vinalop\u00f3",
                    "status": "WITHDRAWN",
                    "city": "Elche",
                    "state": "Alicante",
                    "zip": "03293",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 38.26218,
                        "lon": -0.70107
                    }
                },
                {
                    "facility": "Hospital Universitario de Jerez",
                    "status": "WITHDRAWN",
                    "city": "Jerez De La Frontera",
                    "state": "Cadiz",
                    "zip": "11407",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 36.68645,
                        "lon": -6.13606
                    }
                },
                {
                    "facility": "Start Madrid - Hospital Universitario HM Sanchinarro",
                    "status": "WITHDRAWN",
                    "city": "Madrid",
                    "zip": "28050",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario de Torrej\u00f3n",
                    "status": "WITHDRAWN",
                    "city": "Madrid",
                    "zip": "28850",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Australia"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                },
                {
                    "id": "D000018281",
                    "term": "Cholangiocarcinoma"
                },
                {
                    "id": "D000005706",
                    "term": "Gallbladder Neoplasms"
                },
                {
                    "id": "D000001650",
                    "term": "Bile Duct Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000001661",
                    "term": "Biliary Tract Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000001660",
                    "term": "Biliary Tract Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005705",
                    "term": "Gallbladder Diseases"
                },
                {
                    "id": "D000001649",
                    "term": "Bile Duct Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Bladder Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20559",
                    "name": "Disease Progression",
                    "relevance": "LOW"
                },
                {
                    "id": "M20426",
                    "name": "Cholangiocarcinoma",
                    "asFound": "Cholangiocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8824",
                    "name": "Gallbladder Neoplasms",
                    "asFound": "Gall Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4936",
                    "name": "Bile Duct Neoplasms",
                    "asFound": "Bile Duct Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M4947",
                    "name": "Biliary Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M4946",
                    "name": "Biliary Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8823",
                    "name": "Gallbladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4935",
                    "name": "Bile Duct Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T755",
                    "name": "Bile Duct Cancer",
                    "asFound": "Cholangiocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3096",
                    "name": "Intrahepatic Cholangiocarcinoma",
                    "asFound": "Intrahepatic Cholangiocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2425",
                    "name": "Gallbladder Cancer",
                    "asFound": "Gall Bladder Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000093542",
                    "term": "Gemcitabine"
                },
                {
                    "id": "D000077150",
                    "term": "Oxaliplatin"
                },
                {
                    "id": "D000005472",
                    "term": "Fluorouracil"
                },
                {
                    "id": "C000613593",
                    "term": "Durvalumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M2985",
                    "name": "Gemcitabine",
                    "asFound": "Mg/kg",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M272500",
                    "name": "Durvalumab",
                    "asFound": "Pancreatic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1674",
                    "name": "Oxaliplatin",
                    "asFound": "Min",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8600",
                    "name": "Fluorouracil",
                    "asFound": "According",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M6191",
                    "name": "Leucovorin",
                    "relevance": "LOW"
                },
                {
                    "id": "M29233",
                    "name": "Levoleucovorin",
                    "relevance": "LOW"
                },
                {
                    "id": "M6182",
                    "name": "Cisplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "asFound": "Web-",
                    "relevance": "HIGH"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "relevance": "LOW"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}